Garry co-founded Akoya Biosciences in 2015, and is the Rachford and Carlota A. Harris Professor in the Department of Microbiology and Immunology at Stanford University School of Medicine. As a co-inventor of the CODEX technology, Garry has focused his research efforts on developing novel technologies and computational methods for research into cancer, leukemia, immunology and …
Matt joined the Akoya Biosciences Board of Directors in 2017. Matt brings over 25 years’ experience as a founder and executive manager in the life sciences space including the current Chairman and founder of Asuragen, Mirna Therapeutics and Ambion, which was acquired in 2006 by Applied Biosystems, now Thermo Fisher Scientific. In addition to Akoya, …
Tom has served on the Akoya Board of Directors since the inception of Akoya Biosciences. Tom spent 24 years on the faculty at Stanford University School of Medicine where he remains the Colleen and Robert Haas Professor Emeritus of Medicine and Biomedical Ethics, former Chief of Pulmonary and Critical Care Medicine, and Co-Founder and Director …
Bob has served on Akoya Bioscience’s board since the company’s inception in 2015. Bob was a founder and served as a Managing Director of Telegraph Hill Partners (THP), a growth equity/late-stage venture capital investment firm focused exclusively on healthcare related companies, since its founding in 2001 until August 2020 when he became Partner Emeritus. Prior …
Sign up to receive our eNewsletter, new product updates, events, and more!
